Goldman Sachs analyst issues BUY recommendation for MSFT on May 22, 2024 05:50AM ET. The previous analyst recommendation was Buy.MSFT was trading at $429.04 at issue of the analyst recommendation.The...
Cowen & Co. analyst issues HOLD recommendation for CRM on May 21, 2024 10:33AM ET. The previous analyst recommendation was Hold.CRM was trading at $286.77 at issue of the analyst...
Macquarie analyst issues NEUTRAL recommendation for PANW on May 21, 2024 10:44AM ET. The previous analyst recommendation was Neutral.PANW was trading at $312.7 at issue of the analyst recommendation.The overall...
FBN Securities analyst issues OUTPERFORM recommendation for PANW on May 21, 2024 08:42AM ET. The previous analyst recommendation was Outperform.PANW was trading at $303.395 at issue of the analyst recommendation.The...
Piper Sandler analyst issues NEUTRAL recommendation for PANW on May 21, 2024 08:27AM ET. The previous analyst recommendation was Neutral.PANW was trading at $303.3 at issue of the analyst recommendation.The...
Benchmark analyst issues BUY recommendation for QCOM on May 21, 2024 07:44AM ET. The previous analyst recommendation was Buy.QCOM was trading at $197.76 at issue of the analyst recommendation.The overall...
HSBC analyst issues HOLD recommendation for PANW on May 21, 2024 07:22AM ET. The previous analyst recommendation was Hold.PANW was trading at $323.77 at issue of the analyst recommendation.The overall...
Loop Capital Markets analyst issues HOLD recommendation for PANW on May 21, 2024 08:02AM ET. The previous analyst recommendation was Hold.PANW was trading at $323.77 at issue of the analyst...
Susquehanna analyst issues POSITIVE recommendation for PANW on May 21, 2024 07:53AM ET. The previous analyst recommendation was Positive.PANW was trading at $323.77 at issue of the analyst recommendation.The overall...
Jefferies analyst issues BUY recommendation for PANW on May 21, 2024 06:18AM ET. The previous analyst recommendation was Buy.PANW was trading at $323.77 at issue of the analyst recommendation.The overall...
